Why the study?
Does ACHPA-containing renin inhibitory peptide reduce blood pressure similarly to enalaprilat in conscious one-kidney dogs with renal artery constriction?
Population
Conscious one-kidney dogs before and after tightening a renal artery clamp
Comparison
ACHPA-containing renin inhibitory peptide vs Enalaprilat (0.003-0.1 mg/kg i.v. bolus)
Design
Preclinical
Follow-up
14 days
Authors
Loading...
Supports renin inhibition in experimental renovascular hypertension; leaves open translation to clinical use.
Does ACHPA-containing renin inhibitory peptide reduce blood pressure similarly to enalaprilat in conscious one-kidney dogs with renal artery constriction?
A novel renin inhibitor is as effective as enalaprilat in reducing blood pressure in a canine model of renovascular hypertension.
Smith et al. (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: